In vitro propagation of the prion-like state of yeast Sup35 protein

Science

Volumn 277, Issue 5324, 1997, Pages 381-383

  Paushkin, Sergey V ^a   Kushnirov, Vitaly V ^a   Smirnov, Vladimir N ^a   Ter Avanesyan, Michael D ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN SPONGIOSIS; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; KURU; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SACCHAROMYCES CEREVISIAE; YEAST;

ENDOPEPTIDASES; FUNGAL PROTEINS; MODELS, CHEMICAL; PHENOTYPE; PRIONS; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PRPC PROTEINS; PRPSC PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SOLUBILITY; TRANSFORMATION, GENETIC;

EID: 0030758280     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.277.5324.381     Document Type: Article

References (27)

1. S. B. Prusiner, Science 252, 1515 (1991); Annu. Rev. Micorobiol. 48, 655 (1994).
2. S. B. Prusiner, Science 252, 1515 (1991); Annu. Rev. Micorobiol. 48, 655 (1994).
3. J. S. Griffith, Nature 215, 1043 (1967).
4. D. A. Kocisko et al., ibid. 370, 471 (1994).
5. B. S. Cox, Heredity 20, 505 (1965); M. Aigle and F. Lacroute, Mol. Gen. Genet. 136, 327 (1975).
6. B. S. Cox, Heredity 20, 505 (1965); M. Aigle and F. Lacroute, Mol. Gen. Genet. 136, 327 (1975).
7. R. B. Wickner, Science 264, 566 (1994).
8. S. V. Paushkin et al., EMBO J. 15, 3127 (1996).
9. M. M. Patino, J.-J. Liu, J. R. Glover, S. Lindquist, Science 273, 622 (1996).
10. G. Zhouravleva et al., EMBO J. 14, 4065 (1996); L. Frolova et al., RNA 2, 334 (1996).
11. G. Zhouravleva et al., EMBO J. 14, 4065 (1996); L. Frolova et al., RNA 2, 334 (1996).
12. V. V. Kushnirov et al., Gene 66, 45 (1988).
13. M. D. Ter-Avanesyan et al., Mol. Microbiol. 7, 683 (1993).
14. M. D. Ter-Avanesyan, A. R. Dagkesamanskaya, V. V. Kushnirov, V. N. Smimov, Genetics 137, 671 (1994).
15. S. V. Paushkin, V. V. Kushnirov, V. N. Smimov, M. D. Ter-Avanesyan, Mol. Cell. Biol. 17, 2798 (1997).
16. 2, 1 mM EDTA, 5% glycerol] containing 1 mM phenylmethylsulfonyl fluoride and protease inhibitor mixture as described [Short Protocols in Molecular Biology, F. M. Ausubel et al., Eds. (Wiley, New York, 1992)]. Cell debris was removed by centrifugation at 15,000g for 20 min.
17. S. V. Paushkin, unpublished data .
18. Lysates were prepared as described (13), but without addition of protease inhibitors. Each reaction contained 150 μg of total protein and prateinase K (0.4 to 4.0 μg/ml) (Boehringer Mannheim) in a volume of 50 μl. After a 30-min incubation at 37°C, portions (4 μl) were removed and analyzed by protein immunoblotting with antibody to Sup35p as described (6).
19. psi- (6) or both. Therefore, the extent of conversion reaction was estimated as the Sup35p ratio between cytosolic fraction and sedimented material.
20. F. E. Cohen et al., Science 264, 530 (1994).
21. P. Brown, L. G. Goldfarb, D. C. Gajdusek, Lancet 337, 1019 (1991).
22. J. T. Jarrett and P. T. Lansbury, Cell 73, 1055 (1993).
23. B. Caughey, D. A. Kocisko, G. J. Raymond, P. T. Lansbury Jr., Chem. Biol. 2, 807 (1995).
24. +] strain was loaded onto a 15 to 40% linear sucrose gradient made in buffer A and centrifuged at 180,000g for 3 hours at 4°C. The gradient was fractionated into 0.4-ml portions. The sedimented material was dissolved in a loading volume of buffer A.
25. +] with Sup35ΔSp-encoding multicopy plasmid (13) was treated with ribonuclease A (500 g/ml) for 15 min at 2O°C, a high salt concentration (1 M LiCl), and nonionic detergent (1% Triton X-100) for 20 min at 4°C and sedimented by centrifugation through a sucrose layer as described (16). The sedimented material was treated again as above, resuspended in buffer A, made either 1.25 M or 2.5 M with GuHCl, incubated for 30 min at 4°C, precipitated by centrifugation through a sucrose layer, and resuspended in buffer A for use in the conversion reaction.
26. M. F. Tuite, B. S. Cox, C. S. McLaughlin, FEBS Lett. 225, 205 (1987).
27. We thank L. Kisselev, M. Tuite, and I. Stansfield for critical reading of the manuscript and K. Jones for antibody to Sup45p. Supported by grants from INTAS and the Russian Foundation for Basic Research to (M.D.T.-A.) and from the Wellcome Trust to (V.V.K.).